Indivior (INDV) announced results from a randomized, double-blind clinical trial published in JAMA Network Open. The study found that both the ...
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer (PFE) is running a Phase 2 study titled “AN ...
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results We conducted a prospective ...
A new study finds that risk-based breast cancer screening could be as safe as annual mammograms, but an expert warns it may ...
Doctors typically recommend that people with heart issues like A-Fib avoid caffeine out of fear that it will trigger symptoms. But a study by UC San Francisco and the University of Adelaide concluded ...
A new study led by researchers at Wake Forest University School of Medicine and Atrium Health Levine Cancer has found that a ...
Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the first patient has been randomized in the RASolute ...
Gilead's ARTISTRY-2 trial shows BIC/LEN is non-inferior to Biktarvy in virologically suppressed adults with HIV, with no new safety signals. ARTISTRY-2's design involved a randomized, double-blind ...
The over-the-counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback